OBX vs ODTX: fair value comparison
Obsidian Therapeutics, Inc. and Odyssey Therapeutics, Inc. · Updated 2026-10-19
OBX has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. ODTX has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. Within Healthcare, OBX currently ranks higher by quality score.
| OBX | ODTX | |
|---|---|---|
| Verdict | No estimate yet | No estimate yet |
| Last price | $11.77 | $17.17 |
| 12-month range | $11.77–$18.99 | $16.42–$24.50 |
| Rank by discount to fair value | — | — |
| Rank by quality score | #256 of 301 Healthcare | #258 of 301 Healthcare |
| Quality grade | F | F |
| Leverage | Low | Low |
| RSI zone | Oversold | Neutral |
| 52-week position | The bottom quarter | The bottom quarter |
Full single-stock breakdowns: OBX fair value analysis · ODTX fair value analysis